| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0007 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0008 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0009 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.25 | 0.001 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |